Diane Reckziegel1, Felix Raschke2, William J Cottam1, Dorothee P Auer3. 1. Arthritis Research UK Pain Centre, University of Nottingham, UK Sir Peter Mansfield Imaging Centre, University of Nottingham, UK Division of Clinical Neuroscience, Radiological Sciences, University of Nottingham, UK. 2. Sir Peter Mansfield Imaging Centre, University of Nottingham, UK Division of Clinical Neuroscience, Radiological Sciences, University of Nottingham, UK. 3. Arthritis Research UK Pain Centre, University of Nottingham, UK Sir Peter Mansfield Imaging Centre, University of Nottingham, UK Division of Clinical Neuroscience, Radiological Sciences, University of Nottingham, UK Dorothee.Auer@nottingham.ac.uk.
Abstract
BACKGROUND: This study aims to investigate the role of the mid-anterior cingulate cortex γ-aminobutyric acid levels in chronic nociceptive pain. The molecular mechanisms of pain chronification are not well understood. In fibromyalgia, low mid-anterior cingulate cortex γ-aminobutyric acid was associated with high pain suggesting a role of prefrontal disinhibition. We hypothesize that mid-anterior cingulate cortex GABAergic disinhibition may underpin chronic pain independent of the pain etiology and comorbid negative affect. Proton magnetic resonance spectra were acquired at 3T from the mid-anterior cingulate cortex in 20 patients with chronic painful knee osteoarthritis, and 19 healthy pain-free individuals using a point resolved spectroscopy sequence optimized for detection of γ-aminobutyric acid. Participants underwent questionnaires for negative affect (depression and anxiety) and psychophysical pain phenotyping. RESULTS: No differences in mid-anterior cingulate cortex γ-aminobutyric acid or other metabolite levels were detected between groups. Ratings of perceived intensity of ongoing osteoarthritis pain were inversely correlated with γ-aminobutyric acid (r = -0.758, p < 0.001), but no correlations were seen for negative affect or pain thresholds. The pain γ-aminobutyric acid interrelation remained strong when controlling for depression (r = -0.820, p < 0.001). Combined levels of glutamine and glutamate were unrelated to psychometric or to pain thresholds. CONCLUSION: Our study supports mid-anterior cingulate cortex γ-aminobutyric acid as a potential marker of pain severity in chronic nociceptive pain states independent of negative affect. The findings suggest that GABAergic disinhibition of the salience network may underlie sensitization to averse stimuli as a mechanism contributing to pain chronification.
BACKGROUND: This study aims to investigate the role of the mid-anterior cingulate cortex γ-aminobutyric acid levels in chronic nociceptive pain. The molecular mechanisms of pain chronification are not well understood. In fibromyalgia, low mid-anterior cingulate cortex γ-aminobutyric acid was associated with high pain suggesting a role of prefrontal disinhibition. We hypothesize that mid-anterior cingulate cortex GABAergic disinhibition may underpin chronic pain independent of the pain etiology and comorbid negative affect. Proton magnetic resonance spectra were acquired at 3T from the mid-anterior cingulate cortex in 20 patients with chronic painful knee osteoarthritis, and 19 healthy pain-free individuals using a point resolved spectroscopy sequence optimized for detection of γ-aminobutyric acid. Participants underwent questionnaires for negative affect (depression and anxiety) and psychophysical pain phenotyping. RESULTS: No differences in mid-anterior cingulate cortex γ-aminobutyric acid or other metabolite levels were detected between groups. Ratings of perceived intensity of ongoing osteoarthritis pain were inversely correlated with γ-aminobutyric acid (r = -0.758, p < 0.001), but no correlations were seen for negative affect or pain thresholds. The pain γ-aminobutyric acid interrelation remained strong when controlling for depression (r = -0.820, p < 0.001). Combined levels of glutamine and glutamate were unrelated to psychometric or to pain thresholds. CONCLUSION: Our study supports mid-anterior cingulate cortex γ-aminobutyric acid as a potential marker of pain severity in chronic nociceptive pain states independent of negative affect. The findings suggest that GABAergic disinhibition of the salience network may underlie sensitization to averse stimuli as a mechanism contributing to pain chronification.
Authors: William W Seeley; Vinod Menon; Alan F Schatzberg; Jennifer Keller; Gary H Glover; Heather Kenna; Allan L Reiss; Michael D Greicius Journal: J Neurosci Date: 2007-02-28 Impact factor: 6.167
Authors: Georg Northoff; Martin Walter; Rolf F Schulte; Johannes Beck; Ulrike Dydak; Anke Henning; Heinz Boeker; Simone Grimm; Peter Boesiger Journal: Nat Neurosci Date: 2007-11-04 Impact factor: 24.884
Authors: Luke A Henderson; Chris C Peck; Esben T Petersen; Caroline D Rae; Andrew M Youssef; Jenna M Reeves; Sophie L Wilcox; Rahena Akhter; Greg M Murray; Sylvia M Gustin Journal: J Neurosci Date: 2013-04-24 Impact factor: 6.167
Authors: Yuqing Zhang; Jingbo Niu; Margaret Kelly-Hayes; Christine E Chaisson; Piran Aliabadi; David T Felson Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: A K Suokas; D A Walsh; D F McWilliams; L Condon; B Moreton; V Wylde; L Arendt-Nielsen; W Zhang Journal: Osteoarthritis Cartilage Date: 2012-07-13 Impact factor: 6.576
Authors: Danielle D DeSouza; Katy H Stimpson; Laima Baltusis; Matthew D Sacchet; Meng Gu; Ralph Hurd; Hua Wu; David C Yeomans; Nolan Willliams; David Spiegel Journal: Cereb Cortex Date: 2020-05-18 Impact factor: 5.357
Authors: Aimie L Peek; Andrew M Leaver; Sheryl Foster; Georg Oeltzschner; Nicolaas A Puts; Graham Galloway; Michele Sterling; Karl Ng; Kathryn Refshauge; Maria-Eliza R Aguila; Trudy Rebbeck Journal: J Pain Date: 2021-06-25 Impact factor: 5.820
Authors: Florence B Pomares; Steve Roy; Thomas Funck; Natasha A Feier; Alexander Thiel; Mary-Ann Fitzcharles; Petra Schweinhardt Journal: Pain Date: 2020-01 Impact factor: 7.926
Authors: Leandro Ryuchi Iuamoto; Fábio Luis Kenji Ito; Thales Augusto Tomé; Wu Tu Hsing; Alberto Meyer; Marta Imamura; Linamara Rizzo Battistella Journal: Medicine (Baltimore) Date: 2022-01-21 Impact factor: 1.889